Oxymetholone 50 mg

• Oxymetholone 50 mg
• Brand: Magnus Pharmaceuticals
• Content: 50 tablets | 50 mg per tablet
• Manufactured in: Europe

Product Overview

Oxymetholone 50 mg provides one of the most potent oral anabolic agents available for research. Originally commercialized as Anadrol-50 for anemia treatment, it is now widely studied for hypertrophy models, nitrogen-balance enhancement, glycogen modulation, and erythropoiesis.

Its di-methyl structure and 2-hydroxymethylene group contribute to near-100% oral bioavailability and a high anabolic-to-androgenic ratio. These same structural features, however, result in significant hepatotoxic risk. A short ~8-hour half-life supports twice-daily dosing, while long-lived urinary metabolites enable detection beyond 10 days.

Key Research Highlights

Explosive anabolic potency: AR-binding assays show 2–4 testosterone activity, producing rapid muscle gain

Erythropoiesis support: Clinically effective in increasing red-cell mass for anemia protocols

Nitrogen & glycogen regulation: Enhances carbohydrate use and improves nitrogen retention in catabolic models

Oral PK: ~8-hour half-life with 1–2 h C_max peak; ideal for split-dose trials

Anti-doping relevance: Long-term urinary metabolites yield extended detection via LC-MS/MS

WADA status: Fully banned under S1 category — exposure results in doping violation

Suggested Laboratory Applications

Acute hypertrophy & strength-gain simulations

Nitrogen balance and glycogen metabolism modeling

Erythropoietic support in anemia-related studies

Hepatotoxicity evaluation in DILI-sensitive trials

Anti-doping method validation and exposure tracking

Technical Specifications

Detection Window

10 days via urinary 17-epi metabolites

Documented Benefits

Lean mass, strength, erythropoiesis

Main Risks

Cholestasis, hepatotoxicity, HDL/LDL, hypertension, virilisation

Total Active Compound

2,500 mg per carton (50 mg 50 tablets)

Shelf-life

36 months (manufacturer specification)

PubChem-Supported Research Insights

Rapid lean-mass gain documented in 6-week protocols

Powerful erythropoietic effects in clinical anemia cases

Supports carbohydrate utilization and glycogen sparing

Produces strong nitrogen balance even in catabolic states

Extended detection window critical for anti-doping tests

Documented Research Side Effects

Severe liver stress and cholestasis at moderate doses

Notable dyslipidemia (HDL, LDL), water retention

Androgenic side effects include mood shifts and virilisation

Hypertension and cardiovascular strain at high exposure levels

Handling & Compliance

For Research Use Only — Not for human or veterinary useStore between 15–25°C, protect from moisture and lightPurchase confirms qualified researcher statusHandle in compliance with SDS and lab protocols